The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2019 | Myelomagenesis may start earlier than thought
Ola Landgren, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, outlines a study investigating the onset of multiple myeloma (MM). This analysis investigates the early stages of myelomagenesis, where the acquisition of the first key driver mutations precedes diagnosis by decades. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.
